Pharmafile Logo
Pharmafocus logo
Advanced Search

Sandoz

Showing 15 posts of 76 posts found.

Novartis image

Novartis secures first US biosimilar product

March 6, 2015
Research and Development, Sales and Marketing Amgen, Cancer, FDA, Neupogen, Novartis, Sandoz, Zarxio, biosimilar, filgrastim-sndz

Novartis’ generic arm Sandoz has won the race to become the first company to market a biosimilar in the US …

News
Sandoz image

Sandoz earns historic first FDA biosimilar vote

January 8, 2015
Sales and Marketing FDA, Humira, Novartis, Sandoz, Zarxio, filgrastim, zarzio

Sandoz has taken a huge step forward in the race to be the first company to market a biosimilar in …

News
Sandoz image

Novartis biosimilar rivals Amgen offering

December 9, 2014
Sales and Marketing Amgen, Neupogen, Novartis, Sandoz, filgrastim, zarzio

An investigational biosimilar by Novartis’ generic pharma arm Sandoz has been found to have comparable safety and efficacy readings to …

News
jeff_george_sandoz

Novartis appoints new heads at Alcon, Sandoz

April 9, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alcon, Novartis, Sandoz

Appointment

€16 million fines for J&J and Novartis

December 12, 2013
Medical Communications, Sales and Marketing EU, J&J, JJ, Novartis, Sandoz, fentanyl, fines

The European Commission has slapped multi-million euro fines on Johnson & Johnson and Novartis for what it says were ‘shocking’ …

News

Packaging errors spark fourth oral contraceptive recall

June 12, 2012
Manufacturing and Production Introvale, Novartis, Sandoz, manufacturing, recall

There has been yet another case of an oral contraceptive being recalled because packaging errors could lead to unwanted pregnancy, …

News

Novartis Q1 earnings slide down

April 26, 2012
Sales and Marketing Novartis, Q1, Sandoz, generics, gilenya

Generic competition and problems at a US plant were among the reasons why Novartis’ sales and profit dipped in the …

News

High Court rules against Seroquel XR patent

March 23, 2012
Sales and Marketing Accord, AstraZeneca, Sandoz, Seroquel, Teva

A British High Court has ruled that AstraZeneca’s patent on its new formulation of the antipsychotic Seroquel is invalid. Seroquel …

News

Sandoz falls foul of ABPI Code

March 7, 2012
Medical Communications, Sales and Marketing ABPI Code of Practice, Sandoz

Sandoz has been rapped over the knuckles for offering non-approved bags and bottles to patients.It was found to be offering …

News

Shortages likely as Sandoz’s Canadian plant woes continue

February 20, 2012
Manufacturing and Production FDA, Novartis, Sandoz

Ongoing compliance problems at a plant in Canada operated by Novartis’ generics subsidiary Sandoz look set to cause supply disruptions …

News
Novartis' facility in North Carolina

Novartis warned over standards at generics sites

December 9, 2011
Manufacturing and Production CGMP Failures, FDA compliance, Novartis, Sandoz

The FDA has warned Novartis that three North American production facilities operated by its generics subsidiary Sandoz are failing to …

News

Pharma manufacturing news in brief

January 21, 2011
Manufacturing and Production Cambrex, Faron Pharmaceuticals, McNeil Consumer Healthcare, NextPharma Technologies, Rentschler Biotechnologie, Sandoz, ShangPharma, Sun European Partners, Teva Pharmaceuticals USA, Unilife Corp

Another J&J recall in the US, plus a round-up of product recalls, acquisitions, facility updates and new contracts in the …

News

More US recalls as bill seeks greater FDA powers

January 10, 2011
Manufacturing and Production Centocor Ortho Biotech, Cumberland Pharmaceuticals, FDA, RiteDose Corp, Sandoz, Sigma-tau Pharmasource, Teva Pharmaceuticals, manufacturing compliance, recalls

Product recalls continue to make headlines in the pharmaceutical sector, with several new incidents either side of the New Year …

News

Generic Lovenox to dent Sanofi’s earnings

July 26, 2010
Sales and Marketing Lovenox, Sandoz, Sanofi-Aventis, generics

A generic version of Sanofi-Aventis’ blockbuster anti-blood clot treatment Lovenox has just gained approval in the US, signaling a rapid …

News

Novartis set to boost generic portfolio

April 19, 2010
Sales and Marketing Novartis, Sandoz, generics

Novartis’ generics arm Sandoz has signed a deal to acquire US-based inhalable drug specialist Oriel Therapeutics. Sandoz will gain rights …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026